Voyager Therapeutics
VYGR
VYGR
69 hedge funds and large institutions have $58.6M invested in Voyager Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 32 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
39% less capital invested
Capital invested by funds: $96.8M → $58.6M (-$38.2M)
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
50% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 32
Holders
69
Holding in Top 10
1
Calls
$272K
Puts
$116K
Top Buyers
| 1 | +$1.17M | |
| 2 | +$582K | |
| 3 | +$285K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$276K |
| 5 |
FT
Fiduciary Trust
Boston,
Massachusetts
|
+$245K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$687K | |
| 3 | -$643K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$472K |
| 5 |
JPMorgan Chase & Co
New York
|
-$357K |